For laboratory research use only. Not for human consumption.

Timeline8 milestones

GHK-Cu Research Timeline

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex first isolated from human plasma by Dr. Loren Pickart in 1973. Research over the past five decades has explored its roles in wound healing, tissue remodeling, and gene expression modulation, making it one of the most extensively studied copper peptides in the literature.

1973

Isolation from human plasma

Dr. Loren Pickart identified GHK-Cu while studying factors that differentiated old and young human plasma in liver tissue bioassays. The compound was isolated as a growth-modulating factor present at higher concentrations in younger plasma.

Biochem Biophys Res Commun

1980s

Wound healing research begins

Early studies established that GHK-Cu could stimulate collagen synthesis, glycosaminoglycan production, and decorin accumulation. Researchers documented accelerated wound closure in animal models treated with GHK-Cu formulations.

1988

Collagen synthesis quantified

Studies using rat wound models demonstrated that collagen dressings incorporated with GHK increased collagen synthesis up to 9-fold compared to controls, establishing a quantitative baseline for the compound's effects on extracellular matrix production.

1999–2003

Growth factor secretion research

Research teams documented that GHK-Cu increased secretion of growth factors including bFGF and VEGF in fibroblast cultures. Additional studies explored the compound's effects on nerve outgrowth and blood vessel formation.

2005

Irradiated fibroblast restoration

Pollard et al. published findings in Archives of Facial Plastic Surgery showing that GHK-Cu restored replicative vitality to fibroblasts damaged by radiation exposure, suggesting applications in post-radiation tissue recovery research.

Arch Facial Plast Surg

2010–2012

Broad gene expression profiling

Using the Broad Institute Connectivity Map, researchers revealed that GHK modulates expression of over 4,000 human genes — approximately 6% of the human genome. Gene sets affected included those involved in antioxidant response, inflammation regulation, and tissue remodeling.

2015

Comprehensive pathway review

Pickart published a review in BioMed Research International documenting GHK-Cu's role as a natural modulator of multiple cellular pathways in skin regeneration, consolidating two decades of gene expression and wound healing findings.

Biomed Res Int · PMID: 26236730

2018

Regenerative and protective actions reviewed

Pickart and Margolina published a comprehensive review in the International Journal of Molecular Sciences covering GHK-Cu's documented effects on collagen synthesis, blood vessel and nerve outgrowth, and glycosaminoglycan production across multiple tissue types.

Int J Mol Sci · PMID: PMC6073405

Why This Research Matters

GHK-Cu's research history spans over 50 years, from a basic plasma isolation to one of the most comprehensive gene expression profiles of any single compound. The progression from wound healing observations to genome-wide analysis reflects how peptide research evolves from simple biological assays to systems-level understanding. The breadth of documented gene modulation — over 4,000 genes — positions GHK-Cu as a uniquely well-characterized research compound.

Research Use Compliance

All information presented in this article references published research literature and is intended for educational purposes only. Research peptides are sold strictly for laboratory research use and are not approved for human consumption or medical treatment.